JP5898768B2 - 炎症性腸疾患の治療に使用するためのインデン誘導体 - Google Patents
炎症性腸疾患の治療に使用するためのインデン誘導体 Download PDFInfo
- Publication number
- JP5898768B2 JP5898768B2 JP2014520787A JP2014520787A JP5898768B2 JP 5898768 B2 JP5898768 B2 JP 5898768B2 JP 2014520787 A JP2014520787 A JP 2014520787A JP 2014520787 A JP2014520787 A JP 2014520787A JP 5898768 B2 JP5898768 B2 JP 5898768B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- tert
- mice
- compounds
- dss
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510628P | 2011-07-22 | 2011-07-22 | |
| US61/510,628 | 2011-07-22 | ||
| PCT/IE2012/000037 WO2013014659A1 (en) | 2011-07-22 | 2012-07-20 | Indene derivatives for use in the treatment of inflammatory bowel disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014524921A JP2014524921A (ja) | 2014-09-25 |
| JP2014524921A5 JP2014524921A5 (OSRAM) | 2015-05-07 |
| JP5898768B2 true JP5898768B2 (ja) | 2016-04-06 |
Family
ID=46584089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520787A Expired - Fee Related JP5898768B2 (ja) | 2011-07-22 | 2012-07-20 | 炎症性腸疾患の治療に使用するためのインデン誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9586885B2 (OSRAM) |
| EP (1) | EP2734496A1 (OSRAM) |
| JP (1) | JP5898768B2 (OSRAM) |
| CN (1) | CN103764608B (OSRAM) |
| AU (1) | AU2012288404A1 (OSRAM) |
| BR (1) | BR112014001551A2 (OSRAM) |
| CA (1) | CA2839606A1 (OSRAM) |
| NZ (1) | NZ618936A (OSRAM) |
| RU (1) | RU2601307C2 (OSRAM) |
| TW (1) | TWI537246B (OSRAM) |
| WO (1) | WO2013014659A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2734497A1 (en) * | 2011-07-22 | 2014-05-28 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| CN110426464B (zh) * | 2019-07-08 | 2022-03-04 | 苏州正济药业有限公司 | 一种葡甲胺中异构体的hplc检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE246670T1 (de) * | 1995-12-06 | 2003-08-15 | Venantius Ltd | Indandimerverbindungen mit relaxierender wirkung auf die glatten muskeln und/oder mit mastzellen stabilisiernder und/oder entzuendungshemmender wirkung |
| DE19619036A1 (de) | 1996-04-30 | 1997-11-13 | Schering Ag | Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| AU3899097A (en) * | 1996-08-05 | 1998-02-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted aromatic compounds |
| US20020128256A1 (en) * | 1997-11-20 | 2002-09-12 | Carlo Brugnara | Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation |
| IL136208A0 (en) * | 1997-11-20 | 2001-05-20 | Childrens Medical Center | Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours |
| EP1307455B1 (en) * | 1999-10-20 | 2005-04-06 | Tanabe Seiyaku Co., Ltd. | Inhibitors of alpha-l beta-2 mediated cell adhesion |
| CA2521883C (en) | 2003-04-15 | 2013-09-17 | Inflazyme Pharmaceuticals Ltd. | Indene derivatives as pharmaceutical agents |
| US7592461B2 (en) * | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| EP2734497A1 (en) | 2011-07-22 | 2014-05-28 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| WO2013174917A1 (en) | 2012-05-24 | 2013-11-28 | Venantius Limited | Compounds for use in the treatment of autoimmune inflammatory disease |
| US20150141506A1 (en) | 2012-05-24 | 2015-05-21 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
-
2012
- 2012-07-20 CA CA2839606A patent/CA2839606A1/en not_active Abandoned
- 2012-07-20 BR BR112014001551-1A patent/BR112014001551A2/en not_active IP Right Cessation
- 2012-07-20 US US14/124,937 patent/US9586885B2/en not_active Expired - Fee Related
- 2012-07-20 JP JP2014520787A patent/JP5898768B2/ja not_active Expired - Fee Related
- 2012-07-20 RU RU2013155270/04A patent/RU2601307C2/ru not_active IP Right Cessation
- 2012-07-20 AU AU2012288404A patent/AU2012288404A1/en not_active Abandoned
- 2012-07-20 CN CN201280035083.7A patent/CN103764608B/zh not_active Expired - Fee Related
- 2012-07-20 WO PCT/IE2012/000037 patent/WO2013014659A1/en not_active Ceased
- 2012-07-20 TW TW101126409A patent/TWI537246B/zh not_active IP Right Cessation
- 2012-07-20 EP EP12740702.1A patent/EP2734496A1/en not_active Withdrawn
- 2012-07-20 NZ NZ618936A patent/NZ618936A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2601307C2 (ru) | 2016-11-10 |
| CA2839606A1 (en) | 2013-01-31 |
| JP2014524921A (ja) | 2014-09-25 |
| WO2013014659A1 (en) | 2013-01-31 |
| US9586885B2 (en) | 2017-03-07 |
| CN103764608A (zh) | 2014-04-30 |
| EP2734496A1 (en) | 2014-05-28 |
| AU2012288404A1 (en) | 2014-01-09 |
| BR112014001551A2 (en) | 2017-06-13 |
| US20140128466A1 (en) | 2014-05-08 |
| CN103764608B (zh) | 2016-02-03 |
| TW201311637A (zh) | 2013-03-16 |
| RU2013155270A (ru) | 2015-08-27 |
| TWI537246B (zh) | 2016-06-11 |
| HK1196597A1 (zh) | 2014-12-19 |
| NZ618936A (en) | 2015-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114057692B (zh) | 一种杂环类化合物、其制备方法及用途 | |
| EP2291345B1 (en) | Co-crystals of duloxetine and naproxen | |
| EP2427416B1 (en) | Substituted aromatic compounds and pharmaceutical uses thereof | |
| CN105431432B (zh) | 奎宁类化合物、其光学异构体及其制备方法和医药用途 | |
| US20100087476A1 (en) | Pharmaceutical compounds | |
| JP2019523245A (ja) | オーファン核内受容体Ｎｕｒ７７のリガンド及びその使用 | |
| EP4168384A1 (en) | Thyromimetics | |
| JPS6112907B2 (OSRAM) | ||
| EP3252039B1 (en) | Compound containing indoleacetic acid core structure and use thereof | |
| JP2014524921A (ja) | 炎症性腸疾患の治療に使用するためのインデン誘導体 | |
| JP7049007B2 (ja) | あるメマンチンパロキセチン共晶塩およびその調製方法、薬物構成、応用 | |
| CN110698445B (zh) | 一类3-胺烷基苯酞类化合物、其制备方法和用途 | |
| US9428431B2 (en) | Compositions comprising CB receptor agonists, uses thereof and methods for their preparation | |
| CN114426538A (zh) | 一种小檗碱卡格列净衍生物及其制备方法和应用 | |
| CN114478464B (zh) | 一种炎症小体选择性抑制剂及其合成方法和应用 | |
| US20230331690A1 (en) | Thc derivatives, oral dosage forms comprising same, uses thereof for treating diseases and disorders and synthesis thereof | |
| CN120058667B (zh) | 一种布洛芬-α-硫辛酸共晶及其制备方法与应用 | |
| US10799496B2 (en) | Naphthylenyl compounds for long-acting injectable compositions and related methods | |
| HK1196597B (en) | Indene derivatives for use in the treatment of inflammatory bowel disease | |
| JPH11514383A (ja) | 神経保護活性を有するチアモルヒナン | |
| US20150141506A1 (en) | Indane dimers for use in the treatment of autoimmune inflammatory disease | |
| WO2020094634A1 (en) | Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods | |
| CN116751244A (zh) | α,β-不饱和羰基类18β-甘草次酸衍生物及其制备方法与应用 | |
| HK1241872B (en) | Compound containing indoleacetic acid core structure and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150312 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150312 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150917 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151015 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160115 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160205 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160304 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5898768 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |